+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam



Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam



Journal of Infectious Diseases 192(10): 1720-1726



Rotavirus disease causes a significant health and economic burden worldwide. Several rotavirus vaccines may soon be available for use. A country's decision to introduce these vaccines will depend on its rotavirus disease burden, on the cost of the vaccine, and on the results of an economic assessment of the cost and effectiveness of a rotavirus vaccination program. Data on medical and nonmedical direct costs and indirect costs were established in Khanh Hoa Province, Vietnam, and extrapolated to national estimates on the basis of the birth cohort in 2004. The main outcome measures were economic burden and cost-effectiveness ratio (United States dollars per disability-adjusted life-year averted and dollars per life saved) of vaccination. The disease burden is equivalent to an economic burden of an estimated 3.1 million US dollars in medical direct costs, 685,000 US dollars in nonmedical direct costs, and 1.5 million US dollars in indirect costs. From a societal perspective, treatment of rotavirus disease costs an estimated 5.3 million US dollars per year. From the health care system perspective, universal vaccination of infants at a cost of < or = 7.26 US dollars/vaccine dose would be a cost-effective public health intervention, according to the World Bank cost-effectiveness standard for low-income countries (140 US dollars/disability-adjusted life-year). Vaccination can effectively reduce the disease burden and health care costs of rotavirus-specific diarrhea in Vietnam.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012140043

Download citation: RISBibTeXText

PMID: 16235169

DOI: 10.1086/497339


Related references

Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan. Journal of Infectious Diseases 200(Suppl. 1): S195-S202, 2009

Cost-effectiveness of Rotavirus vaccination in Vietnam. Bmc Public Health 9: 29, 2009

Cost-effectiveness estimates of vaccination against rotavirus in Piedmont, Italy. Journal of Infection and Public Health 11(6): 867-872, 2018

Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium. Medical Decision Making 29(1): 33-50, 2008

Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. Journal of Infectious Diseases 200(Suppl. 1): S76-S84, 2009

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. Journal of Infectious Diseases 200(Suppl. 1): S16-S27, 2009

Cost-effectiveness of rotavirus vaccines in British Columbia: Responding to: Fisman DN, Chan CH, Lowcock E, Naus M, Lee V. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: A model-based evaluation [Vaccine 2012 December 14. Vaccine 31(36): 3637, 2013

Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making. Value in Health Regional Issues 1(1): 7, 2012

Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making. Value in Health Regional Issues 1(1): 7-14, 2012

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries. Vaccine 30(8): 1521-1528, 2012

Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study. Bmc Health Services Research 17(1): 353, 2017

Cost of vaccination and cost of sick leave are determinants of cost-effectiveness vaccination against rotavirus. Ugeskrift for Laeger 174(8): 480-483, 2012

Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China. Vaccine 30(48): 6940-6945, 2013

Projected health impact and cost-effectiveness of rotavirus vaccination among children 5 years of age in China. Vaccine 30(48), 2012

Setting priorities for the health care sector in Zimbabwe using cost-effectiveness analysis and estimates of the burden of disease. Cost Effectiveness and Resource Allocation 6: 14, 2008